Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

Padmanabhan, Balasundaram, Tong, Kit I., Ohta, Tsutomu, Nakamura, Yoshihiro, Scharlock, Maria, Ohtsuji, Makiko, Kang, Moon-Il, Kobayashi, Akira +2 more·2006·Molecular Cell

Cited by (749)

Items 301–400 of 749

  1. Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes
    KyuHan Kim, Jaeyeon Jeong, Young‐Joon Surh, Kyu‐Won Kim · 2009 · Nucleic Acids Research
  2. The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance
    Mohammad Reza Sadeghi, Farhad Jeddi, Narges Soozangar, Mohammad Hossein Somi, Nasser Samadi · 2017 · Tumor Biology
  3. Structural and biochemical characterization of the KLHL3–WNK kinase interaction important in blood pressure regulation
    Schumacher, Frances-Rose, Sorrell, Fiona J., Alessi, Dario R., Bullock, Alex N., Kurz, Thimo · 2014 · Biochemical Journal
  4. The Multifaceted Roles of Autophagy in Tumors—Implications for Breast Cancer
    Jayanta Debnath · 2011 · Journal of Mammary Gland Biology and Neoplasia
  5. Correlation of Nrf2, HO-1, and MRP3 in Gallbladder Cancer and Their Relationships to Clinicopathologic Features and Survival
    Jiansheng Wang, Mingxin Zhang, Lingmin Zhang, Hui Cai, Suna Zhou, Jia Zhang, Yang Wang · 2010 · Journal of Surgical Research
  6. The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
    Melford Chuka Egbujor, Maria Petrosino, Karim Zuhra, Luciano Saso · 2022 · Antioxidants
  7. Nrf2: Friend and Foe in Preventing Cigarette Smoking-Dependent Lung Disease
    Thomas H. Müller, Arnd Hengstermann · 2012 · Chemical Research in Toxicology
  8. Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells
    Chandrani Fouzder, Alpana Mukhuty, Sandip Mukherjee, Chandan Malick, Rakesh Kundu · 2020 · Toxicology in Vitro
  9. Redox regulation of hepatocyte apoptosis
    Carmen García‐Ruiz, José Carlos Fernández-Checa · 2007 · Journal of Gastroenterology and Hepatology
  10. The Cancer Antioxidant Regulation System in Therapeutic Resistance
    Xuanhao Gu, Chunyang Mu, Rujia Zheng, Zhe Zhang, Qi Zhang, Tingbo Liang · 2024 · Antioxidants
  11. Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
    Juan Zhang, Hong‐Xi Xu, Jiaqian Zhu, Yaoxing Dou, Yan‐Fang Xian, Zhi‐Xiu Lin · 2023 · International Journal of Biological Sciences
  12. Increased susceptibility to hepatocarcinogenicity of Nrf2‐deficient mice exposed to 2‐amino‐3‐methylimidazo[4,5‐f]quinoline
    Yasuki Kitamura, Takashi Umemura, Keita Kanki, Yukio Kodama, Sachiko Kitamoto, Koichi Saito, Ken Itoh, Masayuki P. Yamamoto, Toshiaki Masegi, Akiyoshi Nishikawa et al. · 2006 · Cancer Science
  13. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner
    Jong Woo Kim, Min-Ju Kim, Tae-Hee Han, Ji-Yoon Lee, Sangok Kim, Hye‐Rin Kim, Kyoung‐Jin Oh, Won Kon Kim, Baek‐Soo Han, Kwang‐Hee Bae et al. · 2023 · Cell Death and Disease
  14. The Yin and Yang of Nrf2-Regulated Selenoproteins in Carcinogenesis
    Regina Brigelius‐Flohé, Mike F. Müller, Doris Lippmann, Anna Patricia Kipp · 2012 · International Journal of Cell Biology
  15. Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection
    Lorenza P. Ferretti, Sarah-Felicitas Himmels, Anika Trenner, Christina Walker, Christine von Aesch, Aline Eggenschwiler, Olga Murina, Radoslav Ivanov Enchev, Matthias Peter, Raimundo Freire et al. · 2016 · Nature Communications
  16. The p65 Isoform of Nrf1 Is a Dominant Negative Inhibitor of ARE-mediated Transcription
    Weiping Wang, Annie M. Kwok, Jefferson Y. Chan · 2007 · Journal of Biological Chemistry
  17. Novel role of the muskelin–RanBP9 complex as a nucleocytoplasmic mediator of cell morphology regulation
    Manojkumar Valiyaveettil, Amber A. Bentley, Priya R. Gursahaney, Rajaa Hussien, Ritu Chakravarti, Nina Kureishy, Søren Prag, Josephine Clare Adams · 2008 · The Journal of Cell Biology
  18. Nrf2: bane or blessing in cancer?
    Mingjun Xiang, Akhileshwar Namani, ShiJun Wu, XiaoLi Wang · 2014 · Journal of Cancer Research and Clinical Oncology
  19. Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
    Agnieszka Gęgotek, Jacek Nikliński, Neven Žarković, Kamelija Žarković, Georg Waeg, Wojciech Łuczaj, Radosław Charkiewicz, Elźbieta Skrzydlewska · 2016 · Redox Biology
  20. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2‑Related Factor 2 (Nrf2) Protein–Protein Interaction
    Yong Zhang, Zeyu Shi, Yujun Zhou, Qiong Xiao, Hongyue Wang, Ying Peng · 2020 · Journal of Medicinal Chemistry
  21. Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular Apoptosis
    Suryakant K. Niture, Anil K. Jaiswal · 2011 · Journal of Biological Chemistry · Retracted
  22. Prothymosin-α Mediates Nuclear Import of the INrf2/Cul3·Rbx1 Complex to Degrade Nuclear Nrf2
    Suryakant K. Niture, Anil K. Jaiswal · 2009 · Journal of Biological Chemistry · Retracted
  23. p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2
    Erica W. Cloer, Priscila F. Siesser, Emily M. Cousins, Dennis Goldfarb, David D. Mowrey, Joseph S. Harrison, Seth Weir, Nikolay V. Dokholyan, Michael B. Major · 2018 · Molecular and Cellular Biology
  24. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
    Pelin Telkoparan‐Akillilar, Síbel Süzen, Luciano Saso · 2019 · International Journal of Molecular Sciences
  25. Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer
    Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, Roberta Mazzucchelli A · 2023 · Frontiers in Bioscience-Landmark
  26. The see-saw of Keap1-Nrf2 pathway in cancer
    Poorti Pandey, Alok Kumar Singh, Mritunjai Singh, Mallika Tewari, Hari Shankar Shukla, Indrajeet Singh Gambhir · 2017 · Critical Reviews in Oncology/Hematology
  27. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
    Li Guan, Dhanya K. Nambiar, Hongbin Cao, Vignesh Viswanathan, Shirley Kwok, Angela Bik‐Yu Hui, Yuan Hou, Rachel Hildebrand, Rie von Eyben, Brittany Holmes et al. · 2023 · Cancer Research
  28. The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
    Stuart A. Rushworth, David J. MacEwan · 2011 · Cancers
  29. RNAi in Clinical Studies
    Paulina Kubowicz, Dorota Żelaszczyk, Elżbieta Pękala · 2013 · Current Medicinal Chemistry
  30. Oxeiptosis—a cell death pathway to mitigate damage caused by radicals
    Pietro Scaturro, Andreas Pichlmair · 2018 · Cell Death and Differentiation
  31. Dual neuroprotective pathways of a pro‐electrophilic compound via HSF‐1‐activated heat‐shock proteins and Nrf2‐activated phase 2 antioxidant response enzymes
    Takumi Satoh, Tayebeh Rezaie, Masaaki Seki, Carmen R. Sunico, Takahito Tabuchi, Tomomi Kitagawa, Mika Yanagitai, Mutsumi Senzaki, Chihiro Kosegawa, Hideharu Taira et al. · 2011 · Journal of Neurochemistry
  32. Cullin 3 as a novel target in diverse pathologies
    Ana Cristina Andérica‐Romero, Irma Gabriela González-Herrera, Abel Santamarı́a, José Pedraza‐Chaverrí · 2013 · Redox Biology
  33. The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance
    Mirna Jovanović, Ana Podolski-Renić, Mikhail Krasavin, Milica Pešić · 2022 · Frontiers in Molecular Biosciences
  34. NRF2 transcriptionally activates the heat shock factor 1 promoter under oxidative stress and affects survival and migration potential of MCF7 cells
    Soumyadip Paul, Suvranil Ghosh, Sukhendu Mandal, Subrata Sau, Mahadeb Pal · 2018 · Journal of Biological Chemistry
  35. The subcellular localization and activity of cortactin is regulated by acetylation and interaction with Keap1
    Akihiro Ito, Tadahiro Shimazu, Satoko Maeda, Asad Ali Shah, Tatsuhiko Tsunoda, Shun‐ichiro Iemura, Tohru Natsume, Takafumi Suzuki, Hozumi Motohashi, Masayuki P. Yamamoto et al. · 2015 · Science Signaling
  36. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs
    Federico Pio Fabrizio, Angelo Sparaneo, Domenico Trombetta, Lucia Anna Muscarella · 2018 · Oxidative Medicine and Cellular Longevity
  37. Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on In silico perspective
    Ibrahim Damilare Boyenle, Ukachi Chiamaka Divine, Rofiat Oluwabusola Adeyemi, Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, Chowdhry Apu, Lei Du, Qian Lü, Xiaoxing Yin, Temitope Isaac Adelusi · 2021 · Pharmacological Research
  38. DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
    Xin Wang, Tangjun Zhou, Xiao Yang, Xiankun Cao, Gu Jin, Pu Zhang, Jiadong Guo, Kewei Rong, Baixing Li, Yibin Hu et al. · 2023 · Advanced Science
  39. Novel protein–protein interaction inhibitor of Nrf2–Keap1 discovered by structure-based virtual screening
    Hao-Peng Sun, Zhengyu Jiang, Ming-Ye Zhang, Mengchen Lu, Tingting Yang, Yang Pan, Hao‐Ze Huang, Xiaojin Zhang, Qidong You · 2013 · MedChemComm
  40. Activation of Nrf2 by Microcystin-LR Provides Advantages for Liver Cancer Cell Growth
    Nanqin Gan, Xiaoyun Sun, Lirong Song · 2010 · Chemical Research in Toxicology
  41. Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
    Yijun Tian, Kongming Wu, Qian Liu, Na Han, Li Zhang, Qian Chu, Yuan Chen · 2016 · Journal of Hematology & Oncology
  42. Overview of redox regulation by Keap1–Nrf2 system in toxicology and cancer
    Mikiko Suzuki, Akihito Otsuki, Nadine Keleku-Lukwete, Masayuki P. Yamamoto · 2016 · Current Opinion in Toxicology
  43. Structural Biology of CRL Ubiquitin Ligases
    Domnița-Valeria Rusnac, Ning Zheng · 2020 · Advances in experimental medicine and biology
  44. Formation, signaling functions, and metabolisms of nitrated cyclic nucleotide
    Tomohiro Sawa, Hideshi Ihara, Tomoaki Ida, Shigemoto Fujii, Motohiro Nishida, Takaaki Akaike · 2013 · Nitric Oxide
  45. Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2
    Liam Baird, Takafumi Suzuki, Yu Takahashi, Eiji Hishinuma, D. Saigusa, M. Yamamoto · 2020 · Molecular and Cellular Biology
  46. Induction of Heme Oxygenase-1 Inhibits Cell Death in Crotonaldehyde-Stimulated HepG2 Cells via the PKC-δ -p38 -Nrf2 Pathway
    Seung Eun Lee, Hana Yang, Seong Il Jeong, Young-Ho Jin, Cheung-Seog Park, Yong Seek Park · 2012 · PLoS ONE
  47. The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2
    Ziming Li, Ling Xu, Naiwang Tang, Yunhua Xu, Xiangyun Ye, Shengping Shen, Xiaomin Niu, Shun Lü, Zhiwei Chen · 2014 · FEBS Letters
  48. Anthocyanins from Hibiscus syriacus L. Inhibit Oxidative Stress-Mediated Apoptosis by Activating the Nrf2/HO-1 Signaling Pathway
    Ilandarage Menu Neelaka Molagoda, Kyoung Tae Lee, Yung Hyun Choi, Gi‐Young Kim · 2020 · Antioxidants
  49. Keap1–Nrf2 signalling in pancreatic cancer
    Alastair J. Hayes, Christos Skouras, Beate Haugk, Richard Charnley · 2015 · The International Journal of Biochemistry & Cell Biology
  50. Cross-Regulations among NRFs and KEAP1 and Effects of their Silencing on Arsenic-Induced Antioxidant Response and Cytotoxicity in Human Keratinocytes
    Rui Zhao, Yongyong Hou, Qiang Zhang, Courtney Georgette Woods, Peng Xue, Jingqi Fu, Kathy Yarborough, Dawei Guan, Melvin E. Andersen, Jingbo Pi · 2012 · Environmental Health Perspectives
  51. Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival
    Zhongqing Qian, Tong Zhou, Christopher I. Gurguis, Xiaoyan Xu, Qing Wen, Jingzhu Lv, Fang Fang, Louise Hecker, Anne E. Cress, Viswanathan Natarajan et al. · 2015 · Scientific Reports
  52. Select Heterozygous Keap1 Mutations Have a Dominant-Negative Effect on Wild-Type Keap1 In Vivo
    Takafumi Suzuki, Jonathan M. Maher, Masayuki P. Yamamoto · 2010 · Cancer Research
  53. Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
    Chung‐Hang Leung, Jia-Tong Zhang, Guan‐Jun Yang, Hao Liu, Quan‐Bin Han, Dik‐Lung Ma · 2019 · International Journal of Molecular Sciences
  54. Binding thermodynamics and kinetics guided optimization of potent Keap1–Nrf2 peptide inhibitors
    Lu, Meng-Chen, Chen, Zhi-Yun, Wang, Ya-Lou, Jiang, Yong-Lin, Yuan, Zhen-Wei, You, Qi-Dong, Jiang, Zheng-Yu · 2015 · RSC Advances
  55. A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations
    Daniel C. Levings, Xuting Wang, Derek Kohlhase, Douglas A. Bell, Matthew G. Slattery · 2018 · Redox Biology
  56. “Keaping” a lid on lung cancer: the Keap1-Nrf2 pathway
    Sarah A. Best, Kate D. Sutherland · 2018 · Cell Cycle
  57. Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models
    Hye‐Youn Cho, Steven R. Kleeberger · 2015 · Archives of Toxicology
  58. The Involvement ofNRF2in Lung Cancer
    Alison K. Bauer, Thomas Hill, Carla‐Maria Alexander · 2013 · Oxidative Medicine and Cellular Longevity
  59. Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)
    Hai-Shan Zhou, Yan Wang, Qidong You, Zhengyu Jiang · 2020 · Expert Opinion on Therapeutic Patents
  60. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance
    Zahra Payandeh, Abbas Pirpour Tazehkand, Ghasem Barati, Farhad Pouremamali, Houman Kahroba, Behzad Baradaran, Nasser Samadi · 2020 · Biochimie
  61. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
    Zerrin Sezgin Bayındır, Sonia Losada‐Barreiro, Carlos Bravo‐Díaz, Matej Sova, Julijana Kristl, Luciano Saso · 2021 · Antioxidants
  62. Nrf2, the Major Regulator of the Cellular Oxidative Stress Response, is Partially Disordered
    Nadun C. Karunatilleke, Courtney S. Fast, Vy Ngo, Anne M. Brickenden, Martin L. Duennwald, Lars Konermann, Wing‐Yiu Choy · 2021 · International Journal of Molecular Sciences
  63. Keap1–Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein
    Ming‐Hsien Chien, Wei-Jiunn Lee, Feng-Koo Hsieh, Chia-Feng Li, Tsu‐Yao Cheng, Ming-Yang Wang, Jin‐Shing Chen, Jyh‐Ming Chow, Yi‐Hua Jan, Michael Hsiao et al. · 2015 · Clinical Cancer Research
  64. Bisphenol A Activates the Nrf1/2-Antioxidant Response Element Pathway in HEK 293 Cells
    Nikolai Leonidovitch Chepelev, Mutiat I. Enikanolaiye, Leonid L. Chepelev, Abdulrahman Almohaisen, Qixuan Chen, Kylie A. Scoggan, Melanie C. Coughlan, Xu‐Liang Cao, Xiaolei Jin, William Glen Willmore · 2013 · Chemical Research in Toxicology
  65. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    Akhileshwar Namani, Qin Cui, Yihe Wu, Hongyan Wang, Xiu Jun Wang, Xiuwen Tang · 2017 · Oncotarget
  66. FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding
    Kai‐Chun Cheng, Ruey‐Jen Lin, Jing‐Yan Cheng, Sheng‐Hung Wang, Jyh‐Cherng Yu, Jen‐Chine Wu, Yuh‐Jin Liang, Huan-Ming Hsu, John Yu, Alice Lin-Tsing Yu · 2019 · EBioMedicine
  67. Phlorizin exerts potent effects against aging induced by d -galactose in mice and PC12 cells
    Yaojie Liu, Ying Liu, Yatu Guo, Lin Xu, Hao Wang · 2021 · Food & Function
  68. Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics
    Yinghui Tong, Bo Zhang, Yun Fan, Nengming Lin · 2015 · Chronic Diseases and Translational Medicine
  69. Nutrigenomics: Concepts and Applications to Pharmacogenomics and Clinical Medicine
    Jim Kaput, Alla Perlina, Betül Hatipoğlu, Amelia M. Bartholomew, Yuri Nikolsky · 2007 · Pharmacogenomics
  70. From In Silico to a Cellular Model: Molecular Docking Approach to Evaluate Antioxidant Bioactive Peptides
    Federica Tonolo, Alessandro Grinzato, Alberto Bindoli, Maria Pia Rigobello · 2023 · Antioxidants
  71. Genetic mutations associated with lung cancer metastasis to the brain
    Hashim M. Aljohani, Mohamed Aittaleb, John Michael Furgason, Peter Amaya, Ayham Deeb, Jeffery J. Chalmers, El Mustapha Bahassi · 2018 · Mutagenesis
  72. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis
    Xiaolei Zhou, Chong-Yue Zhu, Zhigang Wu, Xin Guo, Wei Zou · 2019 · Oncogene
  73. Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13
    Romain Coppée, Daniel Charlton Jeffares, Maria A. Miteva, Audrey Sabbagh, Jérôme Clain · 2019 · Scientific Reports
  74. Involvement of Nrf2 and Keap1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent peptides from soft-shelled turtle
    Nan Wang, Wei Wang, Faizan Ahmed Sadiq, Shilei Wang, Caiqin Liu, Jin Jianchang · 2020 · Process Biochemistry
  75. Mining Natural Products for Macrocycles to Drug Difficult Targets
    Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, Marie Castaldo, Stefan Geschwindner, Patrik Johansson, Mohit Tyagi, Christian Tyrchan, Lisa Wissler, Peter Sjö et al. · 2020 · Journal of Medicinal Chemistry
  76. Structural analysis of the complex of Keap1 with a prothymosin α peptide
    Balasundaram Padmanabhan, Yoshihiro Nakamura, Shigeyuki Yokoyama · 2008 · Acta Crystallographica Section F Structural Biology and Crystallization Communications
  77. Cell signaling mediated by nitrated cyclic guanine nucleotide
    Akaike, Takaaki, Fujii, Shigemoto, Sawa, Tomohiro, Ihara, Hideshi · 2010 · Nitric Oxide
  78. Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
    Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna · 2024 · International Journal of Molecular Sciences
  79. New Insights into Neuroblastoma Cisplatin Resistance: A Comparative Proteomic and Meta-Mining Investigation
    Simona D’Aguanno, Annamaria D’Alessandro, Luisa Pieroni, Antonella Roveri, Mattia Zaccarin, Valeria Marzano, Michele De Canio, Sergio Bernardini, Giorgio Federici, Andrea Urbani · 2010 · Journal of Proteome Research
  80. Redox Control of Protein–DNA Interactions: From Molecular Mechanisms to Significance in Signal Transduction, Gene Expression, and DNA Replication
    Joseph Shlomai · 2010 · Antioxidants and Redox Signaling
  81. Inflammation, oxidative stress, and higher expression levels of Nrf2 and NQO1 proteins in the airways of women chronically exposed to biomass fuel smoke
    Nandan Kumar Mondal, Hirak Saha, Bidisha Mukherjee, Neetu Tyagi, Manas Ranjan Ray · 2018 · Molecular and Cellular Biochemistry
  82. The Effects of Nuclear Factor Erythroid 2 (NFE2)-Related Factor 2 (Nrf2) Activation in Preclinical Models of Peripheral Neuropathic Pain
    Paramita Basu, Dayna Loyd Averitt, Camelia Gabriela-Anca Maier, Arpita Basu · 2022 · Antioxidants
  83. Synthesis, spectral characterization, chemical reactivity and anticancer behaviors of some novel hydrazone derivatives: Experimental and theoretical insights
    Reşit Çakmak, Eyüp Başaran, Savaş Kaya, Sultan Erkan · 2021 · Journal of Molecular Structure
  84. Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas
    Takayuki Shimizu, Ken-ichi Inoue, Hiroyuki Hachiya, Norisuke Shibuya, Mitsugi Shimoda, Keiichi Kubota · 2013 · Journal of Gastroenterology
  85. Cyclo(His‐Pro) promotes cytoprotection by activating Nrf2‐mediated up‐regulation of antioxidant defence
    Alba Minelli, Carmela Conte, Silvia Grottelli, Ilaria Bellezza, Ivana Cacciatore, Juan Pedro Bolaños · 2008 · Journal of Cellular and Molecular Medicine
  86. ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells
    T. Hojo, Nako Maishi, Alam Mohammad Towfik, Kosuke Akiyama, Noritaka Ohga, Masanobu Shindoh, Yasuhiro Hida, Kazuyuki Minowa, Toshiaki Fujisawa, Kyoko Hida · 2017 · Oncotarget
  87. Applications of the Keap1–Nrf2 system for gene and cell therapy
    Katja M. Kanninen, Yuriy Pomeshchik, Hanna M. Leinonen, Tarja Malm, Jari Koıstınaho, Anna–Liisa Levonen · 2015 · Free Radical Biology and Medicine
  88. The KEAP1-NRF2 System and Esophageal Cancer
    Wataru Hirose, Hiroyuki Oshikiri, Keiko Taguchi, Masayuki P. Yamamoto · 2022 · Cancers
  89. Large-Scale Structural Biology of the Human Proteome
    A.M. Edwards · 2009 · Annual Review of Biochemistry
  90. Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016)
    Haopeng Sun, Jie Zhu, Hongzhi Lin, Kai Xuan Gu, Feng Feng · 2017 · Expert Opinion on Therapeutic Patents
  91. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex
    Martiniano Bello, José A. Morales‐González · 2017 · International Journal of Biological Macromolecules
  92. Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
    Alberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, Alessandra Ferro, Elisabetta Zulato, Ilaria Attili, Giorgia Nardo, Alessandro Dal Maso, Stefano Frega, Andrea Giovanni Menin et al. · 2021 · Translational Lung Cancer Research
  93. NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivity
    Manandhar, Sarala, Choi, Bo-hyun, Jung, Kyeong-Ah, Ryoo, In-geun, Song, Mingu, Kang, Su Jin, Choi, Han-Gon, Kim, Jung-Ae, Park, Pil-Hoon, Kwak, Mi-Kyoung · 2012 · Free Radical Biology and Medicine
  94. Significance of NRF2 in physiological and pathological conditions an comprehensive review
    Michalina Kryszczuk, Oksana Kowalczuk · 2022 · Archives of Biochemistry and Biophysics
  95. Microsecond Molecular Dynamics Simulations of Intrinsically Disordered Proteins Involved in the Oxidative Stress Response
    Elio A. Cino, Jirasak Wong-ekkabut, Mikko Karttunen, Wing‐Yiu Choy · 2011 · PLoS ONE
  96. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model
    Xiangjun Ji, SUI-HUA CHEN, Lin Zhu, Hao Pan, Yuan Zhou, Wei Li, Wanchun You, Chao-Chao Gao, Jianhong Zhu, Kuan Jiang et al. · 2013 · Oncology Reports
  97. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy
    Zhengyu Jiang, Mengchen Lu, Qidong You · 2018 · Journal of Medicinal Chemistry
  98. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
    Laura Torrente, Nicolas Prieto-Farigua, Aimee Falzone, Cody M. Elkins, David A. Boothman, Eric B. Haura, Gina M. DeNicola · 2020 · Redox Biology
  99. Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer
    Nuria Camiña, T.M. Penning · 2021 · British Journal of Cancer
  100. Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
    Shunhao Zhang, Sining Duan, Zhuojun Xie, Wanlin Bao, Bo Xu, Wenbin Yang, Lingyun Zhou · 2022 · Frontiers in Pharmacology